1702 results about "Continuous measurement" patented technology

Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.

Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.

Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.

The present invention relates generally to systems and methods for continuous measurement of a cardiac marker in vivo. In some embodiments, the system includes a continuous sensor and a communication device. The continuous sensor is configured to continuously measure a concentration of a cardiac marker in vivo and to provide a signal associated therewith. The communication device includes a processor module configured to process the signal to obtain cardiac information, wherein the communication device is configured to output the cardiac information.

Systems and methods for continuous measurement of a medicament in vivo are provided. In some embodiments, the system is configured to provide information associated with medicament titration and includes a continuous analyte sensor and a communication device. In some embodiments, the system is configured for continuous ambulatory drug testing, including an ambulatory host monitor having a continuous sensor, a location module, a processor module and a transmitter. In some embodiments, the system is configured for continuously monitoring a hormone level and includes a continuous hormone sensor and a communication device configured to output hormone information in real time. Yet another embodiment provides an analyte sensor for continuous monitoring of a host's nutritional status, and is configured for both continuous glucose detection and continuous albumin detection.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and / or influence of non-constant noise-causing species.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and / or influence of non-constant noise-causing species.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and / or influence of non-constant noise-causing species.

Devices and methods are provided for continuous measurement of an analyte concentration. The device can include a sensor having a plurality of sensor elements, each having at least one characteristic that is different from other sensor(s) of the device. In some embodiments, the plurality of sensor elements are each tuned to measure a different range of analyte concentration, thereby providing the device with the capability of achieving a substantially consistent level of measurement accuracy across a physiologically relevant range. In other embodiments, the device includes a plurality of sensor elements each tuned to measure during different time periods after insertion or implantation, thereby providing the sensor with the capability to continuously and accurately measure analyte concentrations across a wide range of time periods. For example, a sensor system 180 is provided having a first working electrode 150 comprising a first sensor element 102 and a second working electrode 160 comprising a second sensor element 104, and a reference electrode 108 for providing a reference value for measuring the working electrode potential of the sensor elements 102, 104.

Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.

Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and / or influence of non-constant noise-causing species.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and / or influence of non-constant noise-causing species.

The present invention provides a technique for continuous measurement of blood pressure based on pulse transit time and which does not require any external calibration. This technique, referred to herein as the ‘Composite Method’, is carried out with a body-worn monitor that measures blood pressure and other vital signs, and wirelessly transmits them to a remote monitor. A network of body-worn sensors, typically placed on the patient's right arm and chest, connect to the body-worn monitor and measure time-dependent ECG, PPG, accelerometer, and pressure waveforms. The disposable sensors can include a cuff that features an inflatable bladder coupled to a pressure sensor, three or more electrical sensors (e.g. electrodes), three or more accelerometers, a temperature sensor, and an optical sensor (e.g., a light source and photodiode) attached to the patient's thumb.

A method and apparatus for continuous measurement of blood pressure, based on pulse transit time, which does not require any external calibration. This technique, referred to herein as the ‘composite technique’, is carried out with a body-won sensor that measures blood pressure and other vital signs, and wirelessly transmits them to a remote monitor. A network of disposable sensors, typically placed on the patient's right arm and chest, connect to the body sensor and measure a time-dependent electrical waveform, optical waveform, and pressure waveform. The disposable sensors typically include an armband that features an inflatable bladder coupled to a pressure sensor, at least 3 electrical sensors (e.g. electrodes), and an optical sensor (e.g., a light source and photodiode) attached to a wrist-worn band.

The present invention provides a technique for continuous measurement of blood pressure based on pulse transit time and which does not require any external calibration. This technique, referred to herein as the ‘Composite Method’, is carried out with a body-worn monitor that measures blood pressure and other vital signs, and wirelessly transmits them to a remote monitor. A network of body-worn sensors, typically placed on the patient's right arm and chest, connect to the body-worn monitor and measure time-dependent ECG, PPG, accelerometer, and pressure waveforms. The disposable sensors can include a cuff that features an inflatable bladder coupled to a pressure sensor, three or more electrical sensors (e.g. electrodes), three or more accelerometers, a temperature sensor, and an optical sensor (e.g., a light source and photodiode) attached to the patient's thumb.

A fluid management system including a pass-through fluid volume measurement system to provide continuous measurement of fluid returned from a surgical site during transit to a waste collection system. The pass-through fluid volume measurement system eliminates the need to physically replace full fluid collection containers during the medical procedure with new, empty fluid collection containers.

Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.

Position determination accuracy of a wireless communication device may be negatively affected by a large unaccounted GPS doppler bias, which in turn may affect GPS doppler estimations and GPS doppler measurements conducted by the wireless communication device. The quality of GPS doppler measurements is very important for position location, because poor quality GPS doppler measurements may prevent the wireless communication device from acquiring satellites in the most sensitive modes with narrow frequency ranges, which results in reduced GPS pseudorange measurement yield. Large unaccounted GPS doppler bias also adversely affects position accuracy because of the adverse effect on the GPS code phase measurements time propagation to common time prior to their use in position location calculation. The same is true in the case of unaccounted CDMA code doppler, through the adverse effect on the AFLT code phase measurements time propagation to common time prior to their use in a position location engine. This effect is the biggest concern in the case of large search windows. Therefore, the present disclosure provides a method of optimizing GPS based position location in the presence of time-varying frequency error, including the steps of continuously measuring and / or calculating resulting GPS doppler bias and CDMA code doppler bias and then minimizing their adverse effects with regard to position location determination by re-centering GPS doppler search windows based on the GPS doppler bias value, as well as using GPS doppler bias and CDMA code doppler bias value to properly propagate GPS pseudorange and AFLT pilot phase measurements, respectively, to common time prior to their use in a position location engine.

A method and system for gating therapeutic or diagnostic energy to a tissue volume of a medical patient during a selected portion of the patient's respiratory cycle, to thereby diminish inaccuracies in the assumed spatial position of the tissue volume arising from displacements induced by the patient's respiration. The gases flowing to and from the patient's lungs are monitored to provide quasi-continuous measurements as a function of time, of (a) flow rate, (b) pressure, (c) patient lung volume and (d) carbon dioxide concentration. The measurements are utilized to trigger the time period during which the energy is gated on, at the beginning of the selected portion of the respiration cycle; and the time period during which the energy is gated on, is terminated at the end of the selected portion of the respiration cycle.

Simultaneous 2-D room shape reconstruction and self-localization is accomplished using no pre-established infrastructure. A mobile device with co-located microphone and loudspeaker is used to collect echoes reflected by the walls. The system uniquely recovers arbitrary 2-D convex room shape as well as the position of mobile device 10 by collecting and processing distances between three consecutive measurement points as well as acoustic echoes from the device. A practical algorithm for room shape reconstruction and self-localization in the presence of noise and higher order echoes is proposed. Experimental results are provided to demonstrate the effectiveness of the approach.

Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.

The invention discloses a device for measuring six-dimensional position poses of an object, which consists of a laser tracking instrument, a receiver, a computing unit and at least one small-sized laser light emitter, wherein the computing unit and the laser tracking instrument are fixedly arranged on the ground surface; the receiver is arranged on a moving object to be measured; the laser tracking instrument and the receiver communicate with the computing unit; the small-sized laser light emitter is arranged on the laser tracking instrument; a horizontal intersection angle and a pitching intersection angle of the laser tracking instrument are controllable, and the laser tracking instrument is provided with a laser distance measuring instrument; and the laser distance measuring instrument and the small-sized laser light emitter project laser light to a projection panel of the receiver respectively. The laser tracking instrument acquires a three-dimensional position of the receiver, and the computing unit solves three-dimensional postures of the receiver corresponding to a fixed coordinate system on the ground surface according to an azimuth angle of the laser tracking instrument and image data of laser faculae on the projection panel. The device can continuously measure moving objects or static objects in a large space, has the advantages of high precision, quick measuring speed, low cost and convenient arrangement, and can replace an expensive laser tracking instrument for measuring the six-dimensional poses.

Non-invasive wearable systems for continuous measurement of blood glucose concentrations help diabetics maintain best awareness and control. A wearable article such as a wristwatch includes elements integrated therewith to provide for biometric measurements. Specifically, both optical and acoustic transducers are arranged within an article such that they are coupled to tissue in a manner which permits blood analytes measurements to be made. In best versions, a quantum cascade laser is arranged with crystalline acoustic detectors in a photoacoustic effect measurement scheme. Laser pulses stimulate special vibrational states of glucose molecules to produce an acoustic return signal to be received at a piezoelectric detector. A wristwatch case may include a back member which supports arrangements and coupling between the back of the watch, elements contained therein, and tissue in contact with the device.

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the devices include a membrane that has an interference domain designed to reduce the permeation of one or more interferents.

A method and device for continuously calculating the circumference of a body segment is based on the continuous measurement of the extracellular resistance of the body segment. Also disclosed is a method and device for determining the dry weight of a dialysis patient wherein the time at which the dry weight of the patient has been achieved is identified as the time at which the patient's normalized resistivity as a function of time (ρN(t)) is greater than or equal to a minimum level of normalized resistivity in healthy subjects (ρN,H).

The present invention provides a technique for continuous measurement of blood pressure based on pulse transit time and which does not require any external calibration. This technique, referred to herein as the ‘Composite Method’, is carried out with a body-worn monitor that measures blood pressure and other vital signs, and wirelessly transmits them to a remote monitor. A network of body-worn sensors, typically placed on the patient's right arm and chest, connect to the body-worn monitor and measure time-dependent ECG, PPG, accelerometer, and pressure waveforms. The disposable sensors can include a cuff that features an inflatable bladder coupled to a pressure sensor, three or more electrical sensors (e.g. electrodes), three or more accelerometers, a temperature sensor, and an optical sensor (e.g., a light source and photodiode) attached to the patient's thumb.

Methods for displaying results of a spreading activation algorithm and for defining an activation input vector for the spreading activation algorithm are disclosed. A planar disk tree is used to represent the generalized graph structure being modeled in a spreading activation algorithm. Activation bars on some or all nodes of the planar disk tree in the dimension perpendicular to the disk tree encode the final activation level resulting at the end of N iterations of the spreading activation algorithm. The number of nodes for which activation bars are displayed may be a predetermined number, a predetermine fraction of all nodes, or a determined by a predetermined activation level threshold. The final activation levels resulting from activation spread through more than one flow network corresponding to the same generalized graph are displayed as color encoded segments on the activation bars. Content, usage, topology, or recommendation flow networks may be used for spreading activation. The difference between spreading activation through different flow networks corresponding to the same generalized graph may be displayed by subtracting the resulting activation patterns from each network and displaying the difference. The spreading activation input vector is determined by continually measuring the dwell time that the user's cursor spends on a displayed node. Activation vectors at various intermediate steps of the N-step spreading activation algorithm are color encoded onto nodes of disk trees within time tubes. The activation input vector and the activation vectors resulting from all N steps are displayed in a time tube having N+1 planar disk trees. Alternatively, a periodic subset of all N activation vectors are displayed, or a subset showing planar disk trees representing large changes in activation levels or phase shifts are displayed while planar disk trees representing smaller changes in activation levels are not displayed.

A method of determining the analyte concentration of a test sample is described. A temperature gradient is introduced in the test sample and infrared radiation detectors measure radiation at selected analyte absorbance peak and reference wavelengths. Reference and analytical signals are detected. In the presence of the selected analyte, parameter differences between reference and analytical signals are detectable. These parameter differences, having a relationship to analyte concentration, are measured, correlated, and processed to determine analyte concentration in the test sample. Accuracy is enhanced by inducing a periodically modulated temperature gradient in the test sample. The analytical and reference signals may be measured continuously and the parameter difference integrated over the measurement period to determine analyte concentration.